Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus sevoflurane during mitral valve replacement: effects on microRNA-30b, Beclin-1, and autophagy/apoptosis markers
ChiCTR-IPR-14005470Phase 4Recruiting
- Sponsor
- Renmin Hospital of Guangdong Medical University
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Renmin Hospital of Guangdong Medical University. Primary endpoints: Beclin-1, LC3 and 1 more. Started Nov 2014; status: recruiting.
02
Drugs
propofol
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on ChiCTR-IPR-14005470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005470.